Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2012
04/05/2012WO2011140441A3 Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
04/05/2012WO2011119979A3 Antibodies to muc16 and methods of use thereof
04/05/2012WO2011116922A3 Thermoreactive substrate with microgels, method for its preparation, and culture method for biological cells
04/05/2012WO2011113036A3 Compositions and methods for expanding bfu-e cells
04/05/2012US20120084890 Regulatory sequences for expressing gene products in plant reproductive tissue
04/05/2012US20120084889 Novel Fatty Acid Elongation Components and Uses Thereof
04/05/2012US20120084885 Promoter, promoter control elements, and combinations, and uses thereof
04/05/2012US20120084883 High Oil Content Plants
04/05/2012US20120084880 Control of gene expression in plants
04/05/2012US20120084878 Soybean Cultivar 2306521658
04/05/2012US20120084877 Soybean Cultivar 2522121658
04/05/2012US20120084876 Soybean Cultivar 2484721658
04/05/2012US20120084875 Soybean Cultivar 2472221658
04/05/2012US20120084874 Soybean Cultivar 2293921658
04/05/2012US20120084871 Npc1l1 orthologues
04/05/2012US20120083588 Neutral amino acid transporter and gene thereof
04/05/2012US20120083587 Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (ma)
04/05/2012US20120083532 Novel uses
04/05/2012US20120083528 Novel protein kinase modulators and therapeutic uses thereof
04/05/2012US20120083521 Aptamers as agonists
04/05/2012US20120083513 3-Substituted-8-Substituted-3H-Imidazo[5,1-d][1,2,3,5]tetrazin-4-one Compounds and Their Use
04/05/2012US20120083495 Compounds for the treatment of spinal muscular atrophy and other uses
04/05/2012US20120083477 Proteasome inhibitors and uses thereof
04/05/2012US20120083474 Heterocyclic amides as modulators of trpa1
04/05/2012US20120083448 Parathyroid Hormone Peptides And Parathyroid Hormone-Related Protein Peptides And Methods Of Use
04/05/2012US20120083442 Myostatin binding agents
04/05/2012US20120083428 Method and Device for Protein Delivery into Cells
04/05/2012US20120083419 Method and compositions for inhibiting tumorigenesis
04/05/2012US20120083036 Polysaccharide transferase
04/05/2012US20120083035 Modified Cell Lines for Increasing Lentiviral Titers
04/05/2012US20120083034 Ex host maturation of germline stem cells
04/05/2012US20120083033 Production of transgenic avians using improved retroviral vectors
04/05/2012US20120083032 Embryonic stem cell line and method for preparing the same
04/05/2012US20120083024 Materials and Methods for Synthesis of a Flavor and Aroma Volatile in Plants
04/05/2012US20120083020 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
04/05/2012US20120083015 Antibodies against human tweak and uses thereof
04/05/2012US20120083014 Nicotiana Benthamiana Plants Deficient in Xylosyltransferase Activity
04/05/2012US20120083013 Glucosyltransferase specific to position-4 of furofuran-type lignan, and polynucleotide encoding same
04/05/2012US20120083001 Method for transporting potassium ions from front side to back side of lipid bilayer membrane
04/05/2012US20120082996 Il-21 variants
04/05/2012US20120082976 Method of screening for insulin secretion-potentiating agents
04/05/2012US20120082715 Stabilized products, processes and devices for preparing the same
04/05/2012US20120082696 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/05/2012US20120082693 Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strain
04/05/2012US20120082688 In Vitro Generation of Myeloid Derived Suppressor Cells
04/05/2012US20120082682 Il-13 binding protein
04/05/2012US20120082681 Anti-il12rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders
04/05/2012US20120082680 Antagonists of pcsk9
04/05/2012US20120082679 Antagonists of pcsk9
04/05/2012US20120082675 Insulin-like growth factor signaling and integrin
04/05/2012US20120082674 Enterococcus antigens
04/05/2012US20120082673 Human cytokine receptor
04/05/2012US20120082670 Cd33 binding agents
04/05/2012US20120082669 Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions or renal disease associated anemia
04/05/2012US20120082666 Antibody compositions and methods of use
04/05/2012US20120082663 Anti-cmet antagonists
04/05/2012US20120082662 Anti-cmet antagonists
04/05/2012US20120082661 Anti-bcma antibodies
04/05/2012US20120082660 Anti-tnf induced apoptosis (atia) diagnostic markers and therapies
04/05/2012US20120082655 Downregulation of SPY1 by p53 as an essential component of p53-mediated effects
04/05/2012US20120082649 Perivascular mesenchymal precursor cells
04/05/2012US20120082644 Cytokines and neuroantigens for treatment of immune disorders
04/05/2012US20120082622 Macaca fascicularis CCL17
04/05/2012DE102010041985A1 Flexibles Zellkulturträgermaterial mit einer porösen dreidimensionalen Struktur Flexible cell culture substrate having a porous three-dimensional structure
04/05/2012DE102010041958A1 Geeignete Hepatozyten für in-vitro Genotoxitätstests Suitable for hepatocytes in vitro genotoxicity tests
04/05/2012DE102010038155A1 Einem biologischen Gewebe nachgebildete Struktur und Verfahren zu deren Herstellung A simulated biological tissue structure and process for their preparation
04/05/2012DE102010037968A1 Struktur zur Nachbildung eines Sinusoids und Verfahren zu ihrer Herstellung Structure for simulation of a sinusoid and processes for their preparation
04/05/2012CA2813203A1 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier
04/05/2012CA2812756A1 Antibody against human prostaglandin e2 receptor ep4
04/05/2012CA2812745A1 Linker for unimolecular fret biosensor based on principle of fluorescence resonance energy transfer
04/05/2012CA2812707A1 Implantable cell device with supportive and radial diffusive scaffolding
04/05/2012CA2812300A1 Manipulation of stem cell function by p53 isoforms
04/04/2012EP2436788A1 Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
04/04/2012EP2436775A1 Method for screening of regenerative medicine
04/04/2012EP2436765A2 Recombinant factor X with no glycosylation and method for preparing the same
04/04/2012EP2436759A2 Plant stem cell derived from cambium of family solanaceae, and method for isolating and culturing same
04/04/2012EP2436758A2 Plant stem cell derived from cambium of family gingkoaceae and method for the isolation thereof
04/04/2012EP2436757A2 Plant stem cell derived from cambium of family asteraceae and method for the isolated culturing thereof
04/04/2012EP2436690A1 Reversibly photoswitchable polypeptides
04/04/2012EP2436387A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
04/04/2012EP2435567A1 Cdc45l peptides and vaccines including the same
04/04/2012EP2435562A1 Compositions and methods for production of aglycosylated plasminogen
04/04/2012EP2435558A2 Generation of genetically corrected disease-free induced pluripotent stem cells
04/04/2012EP2435557A1 Genetically intact induced pluripotent cells or transdifferentiated cells and methods for the production thereof
04/04/2012EP2435556A1 Method for a rational cell culturing process
04/04/2012EP2435555A2 Method for producing a coated cell culture carrier
04/04/2012EP2435490A1 Swellable synthetic microcarriers for culturing cells
04/04/2012EP2435489A1 Synthetic microcarriers for culturing cells
04/04/2012EP2435488A1 Substrates for adhering, culturing and assaying cells
04/04/2012EP2435471A2 INDUCED DERIVATION OF SPECIFIC ENDODERM FROM hPS CELL-DERIVED DEFINITIVE ENDODERM
04/04/2012EP2435470A1 Muteins of the pyrroline-5-carboxylate reductase 1
04/04/2012EP2435459A1 Utilization of pharmacological chaperones to improve manufacturing and purification of biologics
04/04/2012EP2435067A2 Stem cell targeting
04/04/2012EP2434896A1 In vitro production of oligodendrocytes from human umbilical cord stem cells
04/04/2012EP1994145B1 Production of biologically active proteins
04/04/2012EP1942182B1 Vero cell line which is adapted to grow in suspension, method of obtaining same and viral vaccines
04/04/2012EP1694706B1 Modified anti-cd52 antibody
04/04/2012EP1677820B1 Colorectal cancer antigen
04/04/2012EP1660641B1 Follicular fluid for prolonged growth and survival of cells for cell therapies
04/04/2012EP1660513B9 A ca6 antigen-specific cytotoxic conjugate and methods of using the same
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 1827